Literature DB >> 19575489

Constructive thinking, rational intelligence and irritable bowel syndrome.

Enrique Rey1, Marta Moreno Ortega, Monica-Olga Garcia Alonso, Manuel Diaz-Rubio.   

Abstract

AIM: To evaluate rational and experiential intelligence in irritable bowel syndrome (IBS) sufferers.
METHODS: We recruited 100 subjects with IBS as per Rome II criteria (50 consulters and 50 non-consulters) and 100 healthy controls, matched by age, sex and educational level. Cases and controls completed a clinical questionnaire (including symptom characteristics and medical consultation) and the following tests: rational-intelligence (Wechsler Adult Intelligence Scale, 3rd edition); experiential-intelligence (Constructive Thinking Inventory); personality (NEO personality inventory); psychopathology (MMPI-2), anxiety (state-trait anxiety inventory) and life events (social readjustment rating scale). Analysis of variance was used to compare the test results of IBS-sufferers and controls, and a logistic regression model was then constructed and adjusted for age, sex and educational level to evaluate any possible association with IBS.
RESULTS: No differences were found between IBS cases and controls in terms of IQ (102.0 +/- 10.8 vs 102.8 +/- 12.6), but IBS sufferers scored significantly lower in global constructive thinking (43.7 +/- 9.4 vs 49.6 +/- 9.7). In the logistic regression model, global constructive thinking score was independently linked to suffering from IBS [OR 0.92 (0.87-0.97)], without significant OR for total IQ.
CONCLUSION: IBS subjects do not show lower rational intelligence than controls, but lower experiential intelligence is nevertheless associated with IBS.

Entities:  

Mesh:

Year:  2009        PMID: 19575489      PMCID: PMC2705732          DOI: 10.3748/wjg.15.3106

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Coping ability, stress, productive load, and symptoms.

Authors:  S Epstein; L Katz
Journal:  J Pers Soc Psychol       Date:  1992-05

2.  Constructive thinking and coping with laboratory-induced stress.

Authors:  L Katz; S Epstein
Journal:  J Pers Soc Psychol       Date:  1991-11

3.  Constructive thinking: a broad coping variable with specific components.

Authors:  S Epstein; P Meier
Journal:  J Pers Soc Psychol       Date:  1989-08

4.  Neuroticism, somatic complaints, and disease: is the bark worse than the bite?

Authors:  P T Costa; R R McCrae
Journal:  J Pers       Date:  1987-06

5.  Psychological significance of the irritable colon syndrome.

Authors:  I G Hislop
Journal:  Gut       Date:  1971-06       Impact factor: 23.059

6.  Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction.

Authors:  D A Drossman; R S Sandler; D C McKee; A J Lovitz
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

7.  Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome.

Authors:  R C Smith; D S Greenbaum; J B Vancouver; R C Henry; M A Reinhart; R B Greenbaum; H A Dean; J E Mayle
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

8.  Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.

Authors:  Motoyori Kanazawa; Yuka Endo; William E Whitehead; Michiko Kano; Michio Hongo; Shin Fukudo
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

9.  Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.

Authors:  Wendy M Gonsalkorale; Brenda B Toner; Peter J Whorwell
Journal:  J Psychosom Res       Date:  2004-03       Impact factor: 3.006

10.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.